These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7010977)

  • 1. Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality.
    Ribeiro LG; Brandon TA; Hopkins DG; Reduto LA; Taylor AA; Miller RR
    Am J Cardiol; 1981 Apr; 47(4):835-40. PubMed ID: 7010977
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.
    Jugdutt BI; Hutchins GM; Bulkley BH; Becker LC
    Circ Res; 1981 Sep; 49(3):685-700. PubMed ID: 7020976
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of prostacyclin on some hemodynamic parameters in dogs.
    Filczewski M; Oledzka K
    Pol J Pharmacol Pharm; 1981; 33(5):491-8. PubMed ID: 7038645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renal haemodynamic and excretory actions of prostacyclin (PGI2) in anaesthetized dogs [proceedings].
    Hill TW; Moncada S
    Br J Pharmacol; 1978 Mar; 62(3):413P-414P. PubMed ID: 346131
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of prostacyclin on regional blood flow distribution in anesthetized dogs.
    Schölkens BA; Scholtholt J; Becker R; Jung W; Speth O
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):244-54. PubMed ID: 6762168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric antisecretory and cardiovascular actions of a stable 16-phenoxy prostacyclin analog in the dog.
    Kauffman GL; Whittle BJ; Aures D; Grossman MI
    Adv Prostaglandin Thromboxane Res; 1980; 8():1521-4. PubMed ID: 6990722
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart.
    Kowey PR; Verrier RL; Lown B
    Eur J Pharmacol; 1982 May; 80(1):83-91. PubMed ID: 7047179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin-induced changes in coronary blood flow and oxygen handling in the normal and acutely ischaemic canine myocardium.
    Coker SJ; Parratt JR
    Basic Res Cardiol; 1981; 76(4):457-62. PubMed ID: 7025832
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.
    Lefer AM; Ogletree ML; Smith JB; Silver MJ; Nicolaou KC; Barnette WE; Gasic GP
    Science; 1978 Apr; 200(4337):52-4. PubMed ID: 345441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal actions of prostacyclin.
    Bolger PM; Eisner GM; Ramwell PW; Slotkoff LM
    Nature; 1978 Feb; 271(5644):467-9. PubMed ID: 342971
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting.
    Kieler-Jensen N; Milocco I; Kirnö K; Houltz E; Ricksten SE
    J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):741-7. PubMed ID: 8910153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular actions of prostacyclin (PCI2) in chloralose anaesthetized dogs [proceedings].
    Armstrong JM; Chapple D; Dusting GJ; Hughes R; Moncada S; Vane JR
    Br J Pharmacol; 1977 Sep; 61(1):136P. PubMed ID: 334305
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential sensitivity of regional vascular beds in the dog to low-dose prostacyclin infusion.
    Einzig S; Rao GH; White JG
    Can J Physiol Pharmacol; 1980 Aug; 58(8):940-6. PubMed ID: 7013952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.
    Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573
    [No Abstract]   [Full Text] [Related]  

  • 18. Additional myocardial salvage by coadministration of the epoprostenol analog taprostene to recombinant single-chain urokinase-type plasminogen activator in a canine coronary thrombosis model.
    Groves R; Schneider J; Friderichs E; Giertz H; Flohé L
    Arzneimittelforschung; 1989 Apr; 39(4):534-8. PubMed ID: 2665759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of isoflurane on the extent of myocardial necrosis and on systemic hemodynamics, regional myocardial blood flow, and regional myocardial metabolism in dogs after coronary artery occlusion.
    Davis RF; Sidi A
    Anesth Analg; 1989 Nov; 69(5):575-86. PubMed ID: 2802193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effect of prostacyclin (PGI2) in acute hypoxic respiratory failure.
    Slotman GJ; Machiedo GW; Casey KF; Rush BF
    Surg Forum; 1979; 30():177-9. PubMed ID: 395678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.